Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Apexbio Technology LLC Vorapaxar,5mg CAS# 618385-01-6
SDP

Supplier:  Apexbio Technology LLC A88095

Encompass_Preferred

Vorapaxar is a potent PAR1 inhibitor and antiplatelet that was completed in phase III clinical trial[1]. PAR1 is one of the 4 thrombin receptor types that belong to G-protein coupled receptors super family[1]. By binding to thrombin, the N-terminal at the arginine 41 and serine 42 bond of PAR1 on platelet surface can be enzymatically cleaved, resulting in the activation of platelet and subsequent hemostasis process[1]. Vorapaxar is an ethyl-carbamate molecule that derived from natural himbacine and has been determined to be a selective PAR 1 inhibitor through direct binding[2]. In human plasma enriched with platelets, Vorapaxar was able to inhibit the aggregation of platelet with an IC50 value of 47 nM[2]. In addition, vorapaxar is able to inhibitthe platelet aggregation that triggered by the addition of thrombin receptor activating peptide with an IC50 value of 25 nM[2]. Other sizes are also available. Please inqury us for quote.

Catalog No. 50-224-0144


May include imposed supplier surcharges.
Only null left
Add to Cart
This item is not returnable. View return policy

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.